Investigators: Richard Roberts; Mitchell Gross; Terry Takahashi
Category: 2016
Investigators: Stan Louie; Kathleen Rodgers; Nicos Petasis; Louis Dubeau
Investigators: J. Andrew MacKay, Ph.D. Peter Conti, M.D., Ph.D., Alan Epstein, M.D., Ph.D. Zibo Li, Ph.D.
Innovation: Nanoworm-delivered therapeutics that can bind to more than one target
Clinical significance: New immunotherapies tailored to non-Hodgkin’s lymphoma patients